Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The present study proposes to evaluate the potential cognitive enhancing effects of GLYX-13, an NMDAR partial agonist, among a group of healthy adults and those with psychiatric illness on a series of functional magnetic resonance imaging (fMRI) learning and memory tasks.
Epistemonikos ID: f79fd1b7ff4e8468fbfea3aefd92955416791759
First added on: May 11, 2024